Erhan Eser

Erhan Eser

Auto-generated profile, based on publicly available information

Erhan Eser

Manisa Celal Bayar University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2023 in Teaching and Learning in Medicine
Verified
Journal Article
Closed access
EEErhan Eser
Erhan Eser
ECElif Cil
Elif Cil
NGNesibe Efruz Sen Gundogan
Nesibe Efruz Sen Gundogan
MCMeltem Col
Meltem Col
EYElif Nur Yildirim-Ozturk
Elif Nur Yildirim-Ozturk
MTMustafa Turan
Mustafa Turan
Phenomenon: Physician immigration from other countries is increasing as developed countries continue to be desirable destinations for physicians; however, the determinants of Turkish physicians' migration decisions are still unclear. Despite its wide coverage in the media and among physicians in Türkiye, and being the subject of much debate, there is insufficient data to justify this attention. With this study, we aimed to investigate the tendency of senior medical students in Türkiye to pursue their professional careers abroad and its related factors. Approach: This cross-sectional study involved 9881 senior medical students from 39 different medical schools in Türkiye in 2022. Besides participants' migration decision, we evaluated the push and pull factors related to working, social environment and lifestyle in Türkiye and abroad, medical school education inadequacy, and personal insufficiencies, as well as the socioeconomic variables that may affect the decision to migrate abroad. The analyses were carried out with a participation rate of at least 50%. Findings: Of the medical students, 70.7% had emigration intentions. Approximately 60% of those want to stay abroad permanently, and 61.5% of them took initiatives such as learning a foreign language abroad (54.5%) and taking relevant exams (18.9%). Those who wanted to work in the field of Research & Development were 1.37 (95% CI: 1.22-1.54) times more likely to emigrate. The push factor that was related to emigration intention was the "working conditions in the country" (OR: 1.89, 95% CI: 1.56-2.28) whereas the "social environment/lifestyle abroad" was the mere pull factor for the tendency of emigration (OR: 1.73, 95% CI: 1.45-2.06). In addition, the quality problem in medical schools also had a significant impact on students' decisions (OR: 2.20, 95% CI: 1.83-2.65). Insights: Although the percentage of those who want to emigrate "definitely" was at the same level as in the other developing countries, the tendency to migrate "permanently" was higher in Türkiye. Improving working conditions in the country and increasing the quality of medical faculties seem vital in preventing the migration of physicians.

1 January 2016 in Anatolian Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
HBHakan Baydur
Hakan Baydur
DEDilek Ergin
Dilek Ergin
GGGul Gerceklioglu
Gul Gerceklioglu
EEErhan Eser
Erhan Eser

11 July 2019 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
BÖBörte Gürbüz Özgür
Börte Gürbüz Özgür
HAHatice Aksu
Hatice Aksu
EEErhan Eser
Erhan Eser
Objective: The aim of this study is to present the psychometric properties of the Turkish version of the knowledge about childhood autism among health workers (KCAHW) questionnaire. Methods: Three hundred fifteen primary health care facility workers and 28 child and adolescent mental health professionals were enrolled in this study. Participants filled out socio-demographic data forms and the KCAHW. Reliability analyses consisted of internal consistency and test–retest reliability. For validity analysis, construct validity (confirmatory factor analysis -CFA) and criterion validity were used. Results: The mean KCAHW questionnaire score was 13.83 ± 2.55. The floor effects in all domains were below 15%, the ceiling effects were over 15% in overall score and in Domain 4. Intraclass correlation coefficient and the Kuder Richardson 21 values were 0.83 and 0.683, respectively; All goodness of fit indices generated by CFA were found satisfactory (Comparative fit index = 0.79; Root mean square error of approximation = 0.056, and chi-square/degree of freedom = 1.91). Being a physician, being a CAMH specialist, having mental health clinic experience, having done a child psychiatry internship, knowing someone diagnosed with autism, follow-up experience of a patient with autism, having previous autism training, and the perception of adequate knowledge about autism, significantly increased the KCAHW scores (p < 0.001). Conclusion: The Turkish version of the KCAHW questionnaire is reliable (in terms of test-retest and internal consistency) and valid (sensitive some known/expected external criteria). Due to the insufficient internal consistency in Domain 4, the scores received from Domain 4 should be evaluated with caution.

1 August 2005 in Oncology
Verified
Journal Article
Closed access
MAMeltem Nalca Andrieu
Meltem Nalca Andrieu
CKCengiz Kurtman
Cengiz Kurtman
AHAyse Hicsonmez
Ayse Hicsonmez
MOMahmut Kemal Ozbilgin
Mahmut Kemal Ozbilgin
EEErhan Eser
Erhan Eser
EEEsra Erdemli
Esra Erdemli
Objective: To investigate the early protective effects of amifostine against radiation-induced damage on rat testis tissue. Methods: Eighty adult male Wistar rats were randomized to 4 groups: Saline solution was given to group A for control, 200 mg/kg amifostine (WR-2721) to group B, a single fraction of 6 Gy local irradiation to testes in group C and 200 mg/kg amifostine 15–30 min before 6 Gy testicular irradiation to group D. Animals were sacrificed 3 weeks after treatment and their testes were removed for macroscopic, microscopic and ultrastructural histopathological examination. Results: The weights, widths and lengths of testes in the last 3 groups had decreased significantly when compared with the control group, but the decrease in widths after irradiation was found to be significantly less only in the amifostine plus radiation group. There was a significant reduction of testis weights in relation to the individual body weights in the irradiated testes compared with the other groups (p < 0.005), while there was no significant change of testis weight/total body weight ratio in amifostine plus irradiation group. Spermatogonium A and primary spermatocyte counts were also less in the treatment groups, and primary spermatocyte numbers were significantly higher in amifostine plus radiation group when compared with radiation alone group (p < 0.005). Pretreatment with amifostine reduced the decrease of primary spermatocyte counts by a factor of 1.28. Electron microscopic analysis did not show any cytotoxic effect of amifostine alone, and furthermore, ultrastructural findings were normal with the addition of amifostine prior to irradiation, though there was damage in the radiation exposure group. Conclusion: Amifostine when given alone by itself appears to cause adverse alterations in testis tissue; however, it has a radioprotective effect on spermiogenetic cells when used prior to radiation.

1 August 2020 in Güncel Pediatri
Verified
Journal Article
Closed access
CÇCelalettin Çevik
Celalettin Çevik
SGSoner Güneş
Soner Güneş
SESultan Eser
Sultan Eser
EEErhan Eser
Erhan Eser

18 October 2021 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
ŞAŞebnem Şenol Akar
Şebnem Şenol Akar
SASinem Akçalı
Sinem Akçalı
YÖYunus Özkaya
Yunus Özkaya
FGFatma Merve Gezginci
Fatma Merve Gezginci
BCBeyhan Cengiz
Beyhan Cengiz
EEErhan Eser
Erhan Eser
In this study, it was aimed to prospectively evaluate the efficacy, side effects and seroconversion data of inactive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), CoronaVac (R) (Sinovac, China) vaccine in healthcare workers. A total of 1053 healthcare workers who were initially seronegative (COV2T (R) SARS-CoV-2 Total Siemens, USA) and vaccinated with inactivated SARS-CoV-2 were included in the study. Quantitative IgG antibodies (ADVIA Centaur (R) SARS-CoV-2 IgG, Siemens, USA) were investigated 28 days after the first vaccine (n=939) and the second vaccine (n=771). In addition, neutralizing antibodies were evaluated via "enzyme linked immunosorbent assay (ELISA)" test (ACE2-RBD Neutralization Assay, Dia-Pro, Italy) 28 days after the first vaccine. Antibody response of the vaccine was evaluated statistically by univariate (Chi-square, Fisher's exact test, Student's t test, Mann-Whitney U, one-way ANOVA and Kruskall Wallis ANOVA tests) analysis and linear regression models. The consistency between quantitative IgG test and neutralizing antibody test was also evaluated in blood samples taken 28 days after second vaccination. Statistical analysis was determined in logarithmically transformed data with statistical analysis with SPSS 23.0 and Stata, and type 1 error level was accepted as 0.05. At least one side effect was reported by 31.3% and 26.8% of the participants after the first and second vaccine, respectively. The most frequent side effect was pain at the injection site with a frequency of 20.4% vs 21.7%. The frequency of applying to a health center due to side effects was 1.0% after the first vaccine and 0.8% after the second vaccine. The percentage of those who produced sufficient quantitative IgG was found as 25.3% (95% CI=22.5-28.1) 28 days after the first vaccine and 97.9% (95% CI=96.9198.93) after the second vaccine. Neutralizing test antibody positivity was found as 97.7% 28 days after the second vaccine. In univariate analysis, the characteristics that significantly increased the quantitative IgG response against inactivated SARS-CoV-2 vaccine were young age (p<0.01), female gender (p< 0.01), being a non-smoker (p<0.001), not having a chronic disease (p=0.019), having had the flu vaccine this year (p=0.012), not being overweight or obese (p=0.020), and having a SARS-CoV2 infection prior to vaccination (p<0.001). In addition, allied health personnel showed significantly lower antibody responses than the other workers (p<0.001). Multiple linear regression models revealed that, female gender, younger age, smoking and previous COVID-19 polymerase chain reaction test positivity significantly affected the quantitative IgG response after vaccination. A 99% agreement was found between the ELISA-based neutralizing antibody test and the quantitative IgG test (Kappa p=0.783) performed on the 28th day after the second vaccination. CoronaVac (R) provides adequate antibody response in 25% of healthcare workers aged 18-64, after 28 days from a single vaccine, and 97% after 28 days from the second vaccine. Antibody response was significantly higher in younger ages, women, non-smokers, and those who had previously encountered SARS-CoV-2. Phase 3 and phase 4 results are needed to show effectiveness of this vaccine in real life.